Pyrazolo[1,5-a]pyrimidines. Identification of the privileged structure and combinatorial synthesis of 3-(Hetero)arylpyrazolo[1,5-a]pyrimidine-6- carboxamides

Journal of Combinatorial Chemistry

Volumn 9, Issue 3, 2007, Pages 507-512

  Gregg, Brian T ^a   Tymoshenko, Dmytro O ^a   Razzano, Dana A ^a   Johnson, Matthew R ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; PYRIMIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; COMBINATORIAL CHEMISTRY; METHODOLOGY; STEREOISOMERISM; SYNTHESIS;

AMIDES; COMBINATORIAL CHEMISTRY TECHNIQUES; MOLECULAR STRUCTURE; PYRIMIDINES; STEREOISOMERISM;

EID: 34249935642     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc0700039     Document Type: Article

References (66)

1. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, J. J. Med. Chem. 1988, 31, 2235-2246.
2. (a) Mason, J. S.; Morize, L; Menard, P. R.; Cheney, D. L.; Hulme, C.; Labaudiniere, R. F. J. Med. Chem. 1999, 42, 3251-3264.
3. (b) Patchett, A. A.; Nargund, R. P. In Annual Reports in Medicinal Chemistry; Academic Press: San Diego, CA, 2000; pp 289-298.
4. (c) Sheridan, R. P.; Miller, M. D. J. Chem. Inf. Comput. Sci. 1998, 38, 915-924.
5. Jacobson, K. A.; Kim, Y.-C.; King, B. F. J. Auton. Nerv. Syst. 2000, 81, 152.
6. Pevarello, P.; Amici, R.; Brasca, M. G.; Villa, M.; Varasi, M. Targets Heterocycl. Syst. 1999, 3, 301.
7. (a) Patchett, A. A.; Nargund, R. P. Annu. Rep. Med. Chem. 2000, 35, 289.
8. (b) Austin, J. F.; MacMillan, D. W. C. J. Am. Chem. Soc. 2002, 124, 1172.
9. Kivrakidou, O.; Bralse, S.; Hullshorst, F.; Griebenow, N. Org. Lett. 2004, 6 (7), 1143-1146.
10. (a) Nicolaou, K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G.-Q.; Barluenga, S.; Mitchell, H. J. J. Am. Chem. Soc. 2000, 122 (41), 9939-9953.
11. (b) Nicolaou, K. C.; Pfefferkorn, J. A.; Mitchell, H. J.; Roecker, A. J.; Barluenga, S.; Cao, G.-Q.; Affleck, R. L.; billig, J. E. J. Am. Chem. Soc. 2000, 122 (41), 9954-9967.
12. Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103 (3), 893-930.
13. (a) Chen, C.; Wilcoxen, K. M.; Huang, C. Q.; Xie, Y.-F.; McCarthy, J. R.; Webb, T. R.; Zhu, Y.-F.; Saunders, J.; Liu, X.-J.; Chen, T.-K.; Bozigian, H.; Grigoriadis, D. E. J. Med. Chem. 2004, 47 (19), 4787-4798.
14. (b) Huang, C. Q.; Wilcoxen, K. M.; Grigoriadis, D. E.; McCarthy, J. R.; Chen, C. Bioorg. Med. Chem. Lett. 2004, 14 (15), 3943-3947.
15. (c) Chen, C.; Wilcoxen, K. M.; Huang, C. Q.; McCarthy, J. R.; Chen, T.; Grigoriadis, D. E. Bioorg. Med. Chem. Lett. 2004, 14 (14), 3669-3673.
16. (d) Wustrow, D. J.; Capiris, T.; Rubin, R.; Knobelsdorf, A.; Akunne, H.; Davis, M. D.; MacKenzie, R.; Pugsley, T. A.; Zoski, K. T.; Heffner, T. G.; Wise, L. D. Bioorg. Med. Chem. Lett. 1998, 8 (16), 2067-2070.
17. (a) Selleri, S.; Bruni, F.; Costagli, C.; Costanzo, A.; Guerrini, G.; Ciciani, G.; Gratteri, P.; Besnard, F.; Costa, B.; Montali, M.; Martini, C.; Fohlin, J.; De Siena, G.; Aiello, P. A. J. Med. Chem. 2005, 48 (21), 6756-6760.
18. (b) Lippa, A.; Czobor, P.; Stark, J.; Beer, B.; Kostakis, E.; Gravielle, M.; Bandyopadhyay, S.; Russek, S. J.; Gibbs, T. T.; Farb, D. H.; Skolnick, P. Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (20), 7380-7385.
19. (c) Platt, D. M.; Duggan, A.; Spealman, R. D.; Cook, J. M.; Li, X.; Yin, W.; Rowlett, J. K. J. Pharmacol. Exp. Ther. 2005, 313 (2), 658-667.
20. (d) Kahnberg, P.; Howard, M; H.; Liljefors, T.; Nielsen, M.; Nielsen, E. O.; Sterner, O.; Pettersson, I. J. Mol. Graphics Modell. 2004, 23 (3), 253-261.
21. (e) Foster, A. C.; Pelleymounter, M. A.; Cullen, M. J.; Lewis, D.; Joppa, M.; Chen, T. K.; Bozigian, H. P.; Gross, R. S.; Gogas, K. R. J. Pharmacol. Exp. Ther. 2004, 311 (2), 547-559.
22. (f) Sullivan, S. K.; Petroski, R. E.; Verge, G.; Gross, R. S.; Foster, A. C.; Grigoriadis, D. E. J. Pharmacol. Exp. Ther. 2004, 311 (2), 537-546.
23. (g) Sanger, D. J. CMS Drugs 2004, 18 (1), 9-15.
24. (h) Voss, J.; Sanchez, C.; Michelsen, S.; Ebert, B. Eur. J. Pharmacol. 2003, 482 (1-3), 215-222.
25. (i) Selleri, S.; Bruni, F.; Costagli, C.; Costanzo, A.; Guerrini, G.; Ciciani, G.; Gratteri, P.; Bonaccini, C.; Aiello, P. M.; Besnard, F.; Renard, S.; Costa, B.; Martini, C. J. Med. Chem. 2003, 46 (2), 310-313.
26. (j) George, C. F. P. Lancet 2001, 358 (9293), 1623-1626.
27. (a) Selleri, S.; Gratteri, P.; Costagli, C.; Bonaccini, C.; Costanzo, A.; Melani, F.; Guerrini, G.; Ciciani, G.; Costa, B.; Spinetti, F.; Martini, C.; Bruni, F. Bioorg Med. Chem. 2005, 13 (16), 4821-4834.
28. (b) Guazzelli, M.; Panicucci, P.; Sanna, E.; Biggio, G. In Benzodiazepine; Biggio, G., Ed.; Springer-Verlag Italia: Milan, Italy, 2000; pp 379-400.
29. (c) Selleri, S.; Bruni, F.; Costagli, C.; Costanzo, A.; Guerrini, G.; Ciciani, G.; Costa, B.; Martini, C. Bioorg Med. Chem. 2001, 9(10), 2661-2671.
30. (d) Selleri, S.; Bruni, F.; Costagli, C.; Costanzo, A.; Guerrini, G.; Ciciani, G.; Costa, B.; Martini, C. Bioorg Med. Chem. 1999, 7 (12), 2705-2711.
31. Balakin, K. V.; Tkachenko, S. E.; Lang, S. A.; Okun, I.; Ivashchenko, A. A.; Savchuk, N. P. J. Chem. Inf. Comput. Sci. 2002, 42 (6), 1332-1342.
32. (a) Zhang, H.; Weir, B.; Daniel, E. E. Pharmacology 1995, 50 (4), 247-256.
33. (b) Drizin, I.; Holladay, M. W.; Yi, L.; Zhang, H. Q.; Gopalakrishnan, S.; Gopalakrishnan, M.; Whiteaker, K. L.; Buckner, S. A.; Sullivan, J. P.; Carroll, W. A. Bioorg. Med. Chem. Lett. 2002, 12 (11), 1481-1484.
34. Altenbach, R. J.; Black, L. A.; Chang, S.; Cowart, M. D.; Faghih, R.; Gfesser, G. A.; Ku, Y.; Liu, H.; Lukin, K. A.; Nersesian, D. L.; Pu, Y.; Curtis, M. P. Tri- and Bi-Cyclic Heteroaryl Histamine-3 Receptor Ligands. U.S. Patent Appl. 256309, November 17, 2005.
35. (a) Neubauer, D. N. Expert Opin. Invest. Drugs 2005, 14 (10), 1269-1276.
36. (b) Holzinger, E. Drugs 2005, 8 (5), 410-415.
37. (c) Gilligan, P. J.; Li, Y.-W. Curr. Opin. Drug Discovery Dev. 2004, 7 (4), 487-497.
38. Inoe, M.; Shoji, Y.; Okamura, T.; Hashimoto, K.; Obara, M.; Yasuda, T. Jpn. Patent 07309872, 1995.
39. Li, M.; Wang, S.; Wen, L.; Yang, H.; Zhang, X. J. Heterocycl. Chem. 2005, 42 (5), 925-930.
40. Al-Omran, F.; El-Khair, A. A. J. Heterocycl. Chem. 2005, 42(2), 307-312.
41. Almansa, C. A.; Alberto, F.; Cavalcanti, F. L.; Gomez, L. A.; Miralles, A.; Merlos, M.; Garcia-Rafanell, J.; Forn, J. J. Med. Chem. 2001, 44 (3), 350-361.
42. Selleri, S.; Bruni, F.; Costagli, C.; Costanzo, A.; Guerrini, G.; Ciciani, G.; Aiello, P. M.; Lamaberti, C.; Costa, B.; Martini, C. Med. Chem. Res. 2000, 10 (2), 92-113.
43. Gilligan, P. J. A Corticotropin Releasing Factor Receptor Ligand, Its Enantiomer and Pharmaceutically Acceptable Salts. WO Patent 02/072101, September 19, 2002.
44. Kato, F.; Kimura, H.; Omatsu, M.; Yamamoto, K.; Miyamoto, R. Preventive Or Therapeutic Medicines For Diabetes Containing Fused- Heterocycle Compounds Or Their Salts. WO Patent 02/040485, May 23, 2002.
45. (a) Korodi, F.; Feher, E.; Magyar, E. Process for the Production of N-3-(3-Cyanopyrazolo-[1,5-a]pyrimidin-7-yl)-phenyl]-N-ethylacetamide (Zaleplon). WO Patent 02/100828, December 19, 2002.
46. (b) Tombari, D.; Vechioli, A. Method for Obtaining N-3-(3-cyano-pyrazole[ 1,5-a]pyrimidine-7-yl)-phenyl-N-ethylacetamide. U.S. Patent Appl. 2002/0072605, June 13, 2002.
47. (c) Zheng, L.; Wang, S.; Li, B.; Sun, W. Zhongguo Yaowu Huaxue Zazhi 2001, 11 (6), 353-355.
48. (a) Bartroli, J.; Turmo, E.; Alguero, M.; Boncompte, E.; Vericat, M. L.; Conte, L.; Ramis, J.; Merlos, M.; García-Rafanell, J.; Forn, J. J. Med. Chem. 1998, 41 (11), 1855-1868.
49. (b) Fraley, M. E.; Huffman, W. F.; Rubino, R. S.; Hungate, R. W.; Tebben, A. J.; Rutledge, R. Z.; McFall, R. C.; Huckle, W. R.; Kendall, R. L.; Coll, K. E.; Thomas, K. A. Bioorg. Med. Chem. Lett. 2002, 12 (19), 2767-2770.
50. Mustazza, C.; Del Giudice, M. R.; Borioni, A.; Gatta, F. J. Heterocycl. Chem. 2001, 38 (5), 1119-1129.
51. Greenhill, J. V. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Rees, C. W. Eds.; Pergamon Press: New York, 1984; Vol. 5, pp 305-343.
52. (a) Jourdan, F.; Laduree, D.; Robba, M. J. Heterocycl. Chem. 1994, 31 (2), 305-312.
53. (b) Anderson, E. L.; Casey, J. E.; Greene, L. C.; Lafferty, J. J.; Reiff, H. E. J. Med. Chem. 1964, 7, 259-268.
54. (c) Russell, P. B.; Hitchings, J. H. J. Am. Chem. Soc. 1951, 73 (8), 3763-3770.
55. (d) Bruni, F.; Selleri, S.; Costanzo, A.; Guerrini, G.; Casilli, M. L.; Giusti, L. J. Heterocycl. Chem. 1995, 32 (1), 291-298.
56. (e) Bariin, G. B.; Kotecka, B.; Rieckmann, K. H. Aust. J. Chem. 1996, 49 (6), 647-650.
57. (f) Selleri, S.; Bruni, F.; Costanzo, A.; Guerrini, G.; Casilli, M. L. Farmaco 1995, 50 (10), 679-688.
58. Coates, R. M.; Hobbs, S. J. J. Org. Chem. 1984, 49, 140-152.
59. (a) Weisser, M.; Kaeshammer, J.; Menges, B.; Matsumoto, J.; Nakamura, F.; Ijiro, K.; Shimomura, M.; Mittler, S. J. Am. Chem. Soc. 2000, 122 (1), 87-95.
60. (b) Coppola, G. M.; Zhang, Y. L.; Schuster, H. F.; Russel, M. E.; Hughes, T. E. Bioorg. Med. Chem. Lett. 2000, 10 (14), 1555-1558.
61. (c) Chen, Y.-S.; Lawton, R. G. Tetrahedron Lett. 1997, 38 (33), 5785-5788.
62. (d) Menger, F. M.; Johnson, C. L. Tetrahedron 1967, 23, 19-27.
63. (e) Sakakibara, S.; Inukai, N. Bull. Chem. Soc. Jpn. 1965, 38, 1979-1984.
64. (f) Nutt, R. F.; Chen, K.-M.; Jouille, M. M. J. Org. Chem. 1984, 49 (6), 1013-1021.
65. (g) Ireland, R. E.; Mueller, R. H.; Willard, A. K. J. Org. Chem. 1976, 41 (6), 986-996.
66. (h) Lagarias, J. C.; Houghten, R. A.; Rapoport, H. J. Am. Chem. Soc. 1978, 100 (26), 8202-8209.